Vertex Pharmaceuticals Inc
Close on Nov 2, 2026Market cap $140.20BP/E 32.2Yield –
Vertex Pharmaceuticals Stock Options by Year
Stock Options — Shares outstanding at period-end (M shares) (M)
Vertex Pharmaceuticals Stock Options: 1.15M in FY2025, down 27.7% from a year earlier. That is the lowest of the 11 years on record here.
Where the FY2025 figure comes from
Source: Form 10-K (filed 2026-02-13) ↗
Reported in Form 10-K Note (Stock-based Compensation — Stock Option Activity).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Stock Options — Shares outstanding at period-end (M shares) (M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 1.15 | -27.7% | Form 10-K (filed 2026-02-13) ↗ |
| FY2024 | Dec 31, 2024 | 1.59 | -18.0% | Form 10-K (filed 2026-02-13) ↗ |
| FY2023 | Dec 31, 2023 | 1.94 | -23.3% | Form 10-K (filed 2025-02-13) ↗ |
| FY2022 | Dec 31, 2022 | 2.53 | -29.9% | Form 10-K (filed 2024-02-15) ↗ |
| FY2021 | Dec 31, 2021 | 3.61 | -14.9% | Form 10-K (filed 2023-02-10) ↗ |
| FY2020 | Dec 31, 2020 | 4.24 | -32.4% | Form 10-K (filed 2022-02-09) ↗ |
| FY2019 | Dec 31, 2019 | 6.27 | -26.7% | Form 10-K (filed 2021-02-11) ↗ |
| FY2018 | Dec 31, 2018 | 8.55 | -12.5% | Form 10-K (filed 2020-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 9.77 | -22.7% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 12.6 | +13.5% | Form 10-K (filed 2018-02-15) ↗ |
| FY2015 | Dec 31, 2015 | 11.1 | – | Form 10-K (filed 2017-02-23) ↗ |
Breakdown
What makes up stock Options
- Stock Options — Exercisable shares at period-end (M shares)1.15 · FY2025
- Stock Options — Shares exercised in period (M shares)0.45 · FY2025
- Stock Options — Weighted-average exercise price of options outstanding ($/sh)171 · FY2025
- Stock Options — Aggregate intrinsic value of options outstanding ($M)327 · FY2025
- Stock Options — Aggregate intrinsic value of options exercised ($M)148 · FY2025
- ESPP — Shares issued under Employee Stock Purchase Plan (M shares)0.20 · FY2025
- ESPP — Weighted-average purchase price per share ($/sh)362 · FY2025
- Equity incentive plans — Shares available for future grant (M shares)10.9 · FY2025
Cite this data
StockData. (2026). Vertex Pharmaceuticals Stock Options (M), annual FY2015–FY2025 [Data set]. Compiled from Vertex Pharmaceuticals SEC filings and investor materials. https://stockdatahq.com/stocks/vrtx/kpis/opt-out-sh
See every metric in the Vertex Pharmaceuticals KPI table. Data updated Nov 2, 2026.